Forefront Analytics, LLC reported 21 positions worth $11.86M for the quarter ended Jun 30, 2026, up 22.5% on the prior quarter. It opened 0 new positions, added to 13, trimmed 5 and exited 1. Its largest holding is Nvidia Corp at 33% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| NVDA Nvidia Corp | +5,291 | +37.2% | $1.06M | 32.96% |
| DHR Danaher Corp | +752 | +58.4% | $143.21K | 3.28% |
| PFE Pfizer Inc | +5,120 | +39.1% | $123.29K | 3.7% |
| INCY Incyte Corp | +858 | +20.3% | $97.26K | 4.87% |
| ZURA Zura Bio Ltd | +12.1K | +81.0% | $71.20K | 1.34% |
| ABT Abbott Laboratories | +622 | +12.3% | $56.44K | 4.34% |
| CTMX CytomX Therapeutics, Inc. | +12.6K | +100.6% | $47.09K | 0.792% |
| TMO Thermo Fisher Scientific Inc. | +90 | +15.5% | $45.15K | 2.83% |
| GERN Geron Corp | +33.7K | +61.1% | $43.08K | 0.958% |
| BCYC Bicycle Therapeutics Plc | +7,428 | +51.6% | $31.49K | 0.78% |
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| UNH Unitedhealth Group Inc | -574 | -28.9% | $238.64K | 4.94% |
| LEGN Legend Biotech Corp | -5,091 | -32.5% | $147.03K | 2.57% |
| MREO Mereo BioPharma Group plc | -127.8K | -100.0% | $42.17K | Exited |
| NKTX Nkarta, Inc. | -14.9K | -33.9% | $42.11K | 0.691% |
| EW Edwards Lifesciences Corp | -416 | -6.3% | $37.63K | 4.7% |
| REGN Regeneron Pharmaceuticals, Inc. | -45 | -9.8% | $28.07K | 2.18% |
No new positions this quarter.
| Holding | Shares Sold | Trade Value | Prior Weight |
|---|---|---|---|
| MREO Mereo BioPharma Group plc | -127.8K | $42.17K | 0.436% |
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | NVDA Nvidia Corp | Technology | 19.5K | $3.91M | 32.96% | +5,291 | +37.2% | Added | 0% |
| 2 | JPM Jpmorgan Chase & Co | Financial Services | 4,997 | $1.64M | 13.8% | +13 | +0.3% | Added | 0% |
| 3 | DE Deere & Co | Industrials | 1,172 | $743.20K | 6.27% | +36 | +3.2% | Added | 0% |
| 4 | UNH Unitedhealth Group Inc | Healthcare | 1,409 | $585.80K | 4.94% | -574 | -28.9% | Reduced | 0% |
| 5 | INCY Incyte Corp | Healthcare | 5,091 | $577.12K | 4.87% | +858 | +20.3% | Added | 0% |
| 6 | EW Edwards Lifesciences Corp | Healthcare | 6,158 | $557.05K | 4.7% | -416 | -6.3% | Reduced | 0% |
| 7 | ABT Abbott Laboratories | Healthcare | 5,665 | $514.08K | 4.34% | +622 | +12.3% | Added | 0% |
| 8 | PFE Pfizer Inc | Healthcare | 18.2K | $438.49K | 3.7% | +5,120 | +39.1% | Added | 0% |
| 9 | MDT Medtronic plc | Healthcare | 5,319 | $416.11K | 3.51% | 0 | 0.0% | Unchanged | 0% |
| 10 | DHR Danaher Corp | Healthcare | 2,040 | $388.51K | 3.28% | +752 | +58.4% | Added | 0% |
| 11 | TMO Thermo Fisher Scientific Inc. | Healthcare | 669 | $335.62K | 2.83% | +90 | +15.5% | Added | 0% |
| 12 | OTF Blue Owl Technology Finance Corp. | Financial Services | 29.7K | $306.92K | 2.59% | 0 | 0.0% | Unchanged | 0.01% |
| 13 | LEGN Legend Biotech Corp | Healthcare | 10.6K | $305.20K | 2.57% | -5,091 | -32.5% | Reduced | 0.01% |
| 14 | PM Philip Morris International Inc. | Consumer Staples | 1,463 | $264.60K | 2.23% | +13 | +0.9% | Added | 0% |
| 15 | REGN Regeneron Pharmaceuticals, Inc. | Healthcare | 415 | $258.83K | 2.18% | -45 | -9.8% | Reduced | 0% |
Tip. Select a row to see that position’s full history at Forefront Analytics.
As of its Q2 2026 13F filing, Forefront Analytics, LLC’s five largest positions were Nvidia Corp (NVDA) at 33.0%, Jpmorgan Chase & Co (JPM) at 13.8%, Deere & Co (DE) at 6.3%, Unitedhealth Group Inc (UNH) at 4.9%, Incyte Corp (INCY) at 4.9% of the reported portfolio.
Forefront Analytics, LLC reported a 13F portfolio worth $11.86M across 21 positions for Q2 2026. That is up 22.5% from the previous quarter.
Its largest purchases by value were Nvidia Corp ($1.06M), Danaher Corp ($143.21K), Pfizer Inc ($123.29K). It opened 0 new positions.
Its largest sales by value were Unitedhealth Group Inc ($238.64K), Legend Biotech Corp ($147.03K), Mereo BioPharma Group plc ($42.17K). It exited 1 positions entirely.
From the Form 13F-HR reports Forefront Analytics, LLC files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.